Nordgard et al. first described the correlation of SPOCK2 with human cancer and found that oligonucleotide polymorphism of SPOCK2 gene was associated with deletion of 16q chromosome in breast cancer (Nordgard et al., 2008). This evidence concerns the gene SPOCK2 and breast carcinoma.